Feng Wang

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Inflammatory Response

Tyrosine Kinase

Intellectual Disability

Top Venues

Clinical & translational immunology

The EMBO journal

Proceedings of the National Academy of Sciences of the United States of America

CNS neuroscience & therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Xiaohuan Zhao, Mengqiao Xu, Zhenzhen Zhao, Yimin Wang, Yang Liu, Ting Zhang, Xiaoling Wan, Mei Jiang, Xueting Luo, Yao Shen, Lei Chen, Minwen Zhou, Feng Wang, Xiaodong Sun
Bifidobacterium promotes retinal ganglion cell survival by regulating the balance of retinal glial cells. CNS neuroscience & therapeutics (2023)
Qinlan Wang, Ting Zhu, Naijun Miao, Yingying Qu, Zhuning Wang, Yinong Chao, Jing Wang, Wei Wu, Xinyi Xu, Chenqi Xu, Li Xia, Feng Wang
Disulfiram bolsters T-cell anti-tumor immunity through direct activation of LCK-mediated TCR signaling. The EMBO journal 41 (16) (2022)
Feng Wang, Wenhua Liang, Ruirong Yi, Weifang Wang, Yiwei Shi, Jiqin Zhang, Xiang Xu, Qingcan Wang, Mingyao Liu
Enhancing the antitumor immunity of T cells by engineering the lipid-regulatory site of the TCR/CD3 complex. Cancer immunology research (2022)
Qibing Leng, Marion Tarbe, Qi Long, Feng Wang
Pre-existing heterologous T-cell immunity and neoantigen immunogenicity. Clinical & translational immunology 9 (3) (2020)
Shan Sun, Lingjie Luo, Wenhua Liang, Qian Yin, Jing Guo, Anthony M Rush, Zhibao Lv, Qiming Liang, Michael A Fischbach, Justin L Sonnenburg, Dylan Dodd, Mark M Davis, Feng Wang
Bifidobacterium alters the gut microbiota and modulates the functional metabolism of T regulatory cells in the context of immune checkpoint blockade. Proceedings of the National Academy of Sciences of the United States of America 117 (44) (2020)